Inventor · disambiguated record
Oliver W. Press
Also filed as: PRESS OLIVER · PRESS OLIVER W
7 granted patents·2 pending applications·428 citations·filing 1999–2020
86Inventor score
Files withUNIV WASHINGTON3FRED HUTCHINSON CANCER CENTER2HOFFMAN ALLAN S1HUTCHINSON FRED CANCER RES1UNIV MASSACHUSETTS1
Top patents by PatentIndex Score
9 records- 0198US8003129B2Enhanced transport using membrane disruptive agentsUNIV WASHINGTON·Filed 2008·Granted Aug 23, 2011·106 cites·11 claims
- 0297US7374778B2Enhanced transport using membrane disruptive agentsUNIV WASHINGTON·Filed 2004·Granted May 20, 2008·136 cites·21 claims
- 0395US6835393B2Enhanced transport using membrane disruptive agentsUNIV WASHINGTON·Filed 1999·Granted Dec 28, 2004·185 cites·19 claims
- 0483US11834511B2Compositions and methods for CD20 immunotherapyFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Dec 5, 2023·1 cites·22 claims
- 0570US2014219950A1Enhanced transport using membrane disruptive agentsUNIV MASSACHUSETTS·Filed 2014·Application pending·0 cites
- 0661US8846106B2Enhanced transport using membrane disruptive agentsHOFFMAN ALLAN S·Filed 2011·Granted Sep 30, 2014·0 cites·12 claims
- 0758US10875927B2Compositions and methods for CD20 immunotherapyHUTCHINSON FRED CANCER RES·Filed 2017·Granted Dec 29, 2020·0 cites·3 claims
- 0847US2013309171A1Pre-targeted nanoparticle system and method for labeling biological particlesUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Application pending·0 cites
- 0944US11970542B2Bispecific antibodies specific for treating hematological malignanciesFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Apr 30, 2024·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →